Posted On: 08/10/2014 5:52:56 PM
Post# of 30066
Re: gobears1985 #3534
gobears: Excellent post! That is how I feel. The things Gerald is bringing forth are complicated. Deadlines might have been postponed, but nothing has been scrapped. That's what's important.
I've only been in one other small biotech like AMBS that rocketed from nowhere to stardom, but it took patience. There were times it looked so dark and my wife thought I was a fool. Then finally, the stock really did explode upward as I had hoped.
AMBS has far more potential than my other stock. LymPro success is knocking at the door:
Within one month we'll have the "bridge data," revenue guidance, and a partner!
Within three months we'll get a larger validation for LymPro in our Partner's lab.
Within four months or so we'll begin commercialization and Gerald will go on a media blitz promoting it!
By the first half of 2015 we'll have MODEST LymPro revenue.
By the second half of 2015 we'll have MODERATE LymPro revenue.
By the first half of 2016 we'll have OUTRAGEOUS LymPro revenue!!!
I've only been in one other small biotech like AMBS that rocketed from nowhere to stardom, but it took patience. There were times it looked so dark and my wife thought I was a fool. Then finally, the stock really did explode upward as I had hoped.
AMBS has far more potential than my other stock. LymPro success is knocking at the door:
Within one month we'll have the "bridge data," revenue guidance, and a partner!
Within three months we'll get a larger validation for LymPro in our Partner's lab.
Within four months or so we'll begin commercialization and Gerald will go on a media blitz promoting it!
By the first half of 2015 we'll have MODEST LymPro revenue.
By the second half of 2015 we'll have MODERATE LymPro revenue.
By the first half of 2016 we'll have OUTRAGEOUS LymPro revenue!!!
(0)
(0)
